| 2025 |
Hindes, M. T., McElligott, A. M., Best, O. G., Ward, M. P., Selemidis, S., Miles, M. A., . . . Brooks, D. A. (2025). Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Letters, 611(217441), 217441-1-217441-18.
DOI Scopus7 WoS7 Europe PMC3 |
| 2025 |
Chu, B., Modi, N. D., Menz, B. D., Bacchi, S., Kichenadasse, G., Paterson, C., . . . Hopkins, A. M. (2025). Generative AI’s healthcare professional role creep: a cross-sectional evaluation of publicly accessible, customised health-related GPTs. Frontiers in Public Health, 13, 1584348-1-1584348-8.
DOI Scopus2 WoS1 |
| 2025 |
Modi, N. D., Menz, B. D., Awaty, A. A., Alex, C. A., Logan, J. M., McKinnon, R. A., . . . Hopkins, A. M. (2025). Assessing the system-instruction vulnerabilities of large language models to malicious conversion into health disinformation chatbots. Annals of Internal Medicine, 178(8), 1172-1180.
DOI Scopus4 Europe PMC3 |
| 2025 |
Modi, N. D., Abuhelwa, A. Y., Kuderer, N. M., Li, L. X., Lyman, G. H., Koczwara, B., . . . Hopkins, A. M. (2025). Associations of commonly used concomitant medications with survival and adverse event outcomes in breast cancer. Cancer Medicine, 14(21, article no. e71320), 1-10.
DOI Europe PMC1 |
| 2025 |
Lam, G., Martini, C., Sorvina, A., Hickey, S., Hindes, M., Waugh, D., . . . Logan, J. (2025). Implications of Altered Endosomal-Lysosomal Biogenesis in Melanoma Pathogenesis. International Journal of Molecular Sciences, 26(20, article no. 10113), 1-15.
DOI |
| 2025 |
Shakerdi, A. L., Finnegan, E., Sheng, Y. Y., Vidovic, K., Logan, J. M., Ward, M. P., . . . Tewari, P. (2025). Crosstalk between inflammasome signalling and epithelial-mesenchymal transition in cancer and benign disease: mechanistic insights, context-dependence, and therapeutic opportunities. Cells, 14(20, article no. 1594), 1-23.
DOI |
| 2025 |
Li, K. L., Hickey, S. M., Albrecht, H., Logan, J. M., Lazniewska, J., Moore, C. R., . . . Brooks, D. A. (2025). Targeting prostate cancer cells using anti-sortilin and anti-syndecan-1 antibody drug conjugates. International Journal Of Molecular Sciences, 26(22, article no. 11145), 25 pages.
DOI |
| 2025 |
Modi, N. D., Li, L. X., Logan, J. M., Wiese, M. D., Abuhelwa, A. Y., McKinnon, R. A., . . . Hopkins, A. M. (2025). The state of individual participant data sharing for the highest-revenue medicines. Clinical Trials, 22(2), 170-177.
DOI |
| 2024 |
Nturubika, B. D. D., Logan, J., Johnson, I. R. D., Moore, C., Li, K. L., Tang, J., . . . Brooks, D. A. (2024). Components of the endosome-lysosome vesicular machinery as drivers of the metastatic cascade in prostate cancer. Cancers, 17(1), 1, article no. 43-31.
DOI Scopus2 WoS2 Europe PMC1 |
| 2024 |
Bates, M., Mullen, D., Lee, E., Costigan, D., Brooks, R. D., Brooks, D. A., . . . O'Leary, J. J. (2024). P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer. Pathology Research and Practice, 253(155020), 8 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Miles, M. A., Luong, R., To, E. E., Erlich, J. R., Liong, S., Liong, F., . . . Selemidis, S. (2024). TLR9 monotherapy in immune-competent mice suppresses orthotopic prostate tumor development. Cells, 13(1, article no. 97), 1-22.
DOI Scopus3 WoS3 Europe PMC2 |
| 2024 |
Tang, J., Lam, G. T., Brooks, R. D., Miles, M., Useckaite, Z., Johnson, I. R., . . . Logan, J. M. (2024). Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system. Cancer Letters, 585(216639), 216639-1-216639-9.
DOI Scopus9 WoS11 Europe PMC11 |
| 2024 |
Logan, J. M., Martini, C., Sorvina, A., Johnson, I. R. D., Brooks, R. D., Caruso, M. C., . . . Ung, B. S. -Y. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific data, 11(1), 852-1-852-10.
DOI Scopus3 WoS2 Europe PMC1 |
| 2024 |
Nturubika, B. D., Guardia, C. M., Gershlick, D. C., Logan, J. M., Martini, C., Heatlie, J. K., . . . Johnson, I. R. D. (2024). Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression. British Journal of Cancer, 131(8), 1263-1278.
DOI Scopus2 WoS2 Europe PMC2 |
| 2024 |
Menz, B. D., Kuderer, N. M., Chin Yee, B., Logan, J. M., Rowland, A., Sorich, M. J., & Hopkins, A. M. (2024). Gender representation of health care professionals in large language model-generated stories. JAMA network open, 7(9, article no. e2434997), 1-12.
DOI |
| 2023 |
Logan, J. M., Hopkins, A. M., Martini, C., Sorvina, A., Tewari, P., Prabhakaran, S., . . . Brooks, D. A. (2023). Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.. Cancers, 15(12), 1-12.
DOI Scopus10 WoS9 Europe PMC7 |
| 2023 |
Sorvina, A., Martini, C., Prabhakaran, S., Logan, J. M., Ung, B. S. Y., Moore, C., . . . Brooks, D. A. (2023). Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread. Pathology, 55(6), 792-799.
DOI Scopus10 WoS10 Europe PMC9 |
| 2023 |
Lam, G. T., Sorvina, A., Martini, C., Prabhakaran, S., Ung, B. S. Y., Lazniewska, J., . . . Logan, J. M. (2023). Altered endosomal-lysosomal biogenesis in melanoma. Neoplasia, 43(100924), 1-10.
DOI Scopus5 WoS5 Europe PMC3 |
| 2023 |
Lazniewska, J., Li, K. L., Johnson, I. R. D., Sorvina, A., Logan, J. M., Martini, C., . . . Brooks, D. A. (2023). Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression. Scientific reports, 13(1, article no. 13489), 1-18.
DOI Scopus13 WoS12 Europe PMC10 |
| 2023 |
Lam, G. T., Martini, C., Brooks, T., Prabhakaran, S., Hopkins, A. M., Ung, B. S. -Y., . . . Logan, J. M. (2023). Insights into Melanoma Clinical Practice: A Perspective for Future Research. Cancers, 15(18), 4631-1-4631-9.
DOI Scopus3 WoS3 Europe PMC3 |
| 2023 |
Martini, C., Logan, J. M., Sorvina, A., Prabhakaran, S., Ung, B. S. Y., Johnson, I. R. D., . . . Brooks, D. A. (2023). Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 485(4), 723-728.
DOI Scopus3 WoS3 Europe PMC2 |
| 2023 |
Martini, C., Logan, J. M., Sorvina, A., Prabhakaran, S., Ung, B. S. Y., Johnson, I. R. D., . . . Brooks, D. A. (2023). Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer (Virchows Archiv, (2023), 10.1007/s00428-023-03643-1). Virchows Archiv, 487(1), 245.
DOI |
| 2023 |
Miles, M. A., Liong, S., Liong, F., Coward Smith, M., Trollope, G. S., Oseghale, O., . . . Selemidis, S. (2023). TLR7 promotes chronic airway disease in RSV-infected mice. Frontiers In Immunology, 14, 1-21.
DOI Scopus6 WoS6 Europe PMC6 |
| 2023 |
Martini, C., Logan, J. M., Sorvina, A., Gordon, C., Beck, A. R., S-Y Ung, B., . . . Brooks, D. A. (2023). Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer. Pathology, 55(1), 40-51.
DOI Scopus19 WoS18 Europe PMC18 |
| 2023 |
Modi, N. D., Kichenadasse, G., Hoffmann, T. C., Haseloff, M., Logan, J. M., Veroniki, A. A., . . . Hopkins, A. M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21(1), 400.
DOI Scopus17 Europe PMC12 |
| 2023 |
Hopkins, A. M., Logan, J. M., Kichenadasse, G., & Sorich, M. J. (2023). Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift. JNCI Cancer Spectrum, 7(2), 1-3.
DOI |
| 2022 |
Hopkins, A. M., Kichenadasse, G., McKinnon, R. A., Abuhelwa, A. Y., Logan, J. M., Badaoui, S., . . . Sorich, M. J. (2022). Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150. British Journal of Cancer, 126(1), 42-47.
DOI |
| 2022 |
Hopkins, A. M., Abuhelwa, A. Y., McKinnon, R. A., Logan, J. M., Kichenadasse, G., Rowland, A., & Sorich, M. J. (2022). Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: an individual participant data meta-analysis of atezolizumab clinical trials. Smoking and immunotherapy efficacy in lung cancer. European Journal of Cancer, 160, 279-281.
DOI |
| 2022 |
Lam, G. T., Prabhakaran, S., Sorvina, A., Martini, C., Ung, B. S. Y., Karageorgos, L., . . . Logan, J. M. (2022). Pitfalls in cutaneous melanoma diagnosis and the need for new reliable markers. Molecular Diagnosis and Therapy, 27(1), 49-60.
DOI Scopus15 WoS14 Europe PMC12 |
| 2022 |
Hickey, S. M., Ung, B., Bader, C., Brooks, R., Lazniewska, J., Johnson, I. R. D., . . . Brooks, D. A. (2022). Fluorescence microscopy-an outline of hardware, biological handling, and fluorophore considerations. Cells, 11(35), 1-32.
DOI Scopus89 WoS70 Europe PMC48 |
| 2021 |
Logan, J. M., Brooks, D. A., Rowland, A., Sorich, M. J., & Hopkins, A. M. (2021). Survival outcomes of nonsmall cell lung cancer patients treated with afatinib who are affected by early adverse events. Journal of Oncology, 2021(article no. 2414897), 1-6.
DOI Scopus1 WoS1 Europe PMC1 |
| 2021 |
Logan, J. M., Beck, A., Dunstan, N., Allen, L., & Woods, A. E. (2021). Development of the venom delivery system in Elapidae snake species: Naja siamensis and Oxyuranus microlepidotus. Toxicon, 199, 12-19.
DOI |
| 2021 |
Hopkins, A. M., Kichenadasse, G., Logan, J. M., Rowland, A., & Sorich, M. J. (2021). RE: Smoking history as a potential predictor of immune checkpoint inhibitor efficacy in metastatic non-small cell lung cancer. JNCI, 114(3, article no. djab159), 475-476.
DOI |
| 2020 |
Modi, N. D., Sorich, M. J., Rowland, A., Logan, J. M., McKinnon, R. A., Kichenadasse, G., . . . Hopkins, A. M. (2020). A literature review of treatment-specific clinical prediction models in patients with breast cancer. Critical Reviews in Oncology Hematology, 148(102908), 8 pages.
DOI Scopus15 WoS12 Europe PMC11 |
| 2020 |
Ruanglertboon, W., Sorich, M. J., Logan, J. M., Rowland, A., & Hopkins, A. M. (2020). The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib. Journal of Cancer Research and Clinical Oncology, 146(10), 2693-2697.
DOI |
| 2019 |
Johnson, I. R. D., & Logan, J. M. (2019). 'Seeing is Believing': enhancing student engagement with dynamic protein-model visualization. Biochemistry and molecular biology education, 47(3), 247-248.
DOI |
| 2019 |
Mutuku, S. M., Trim, P. J., Prabhala, B. K., Irani, S., Bremert, K. L., Logan, J. M., . . . Butler, L. M. (2019). Evaluation of small molecule drug uptake in patient-derived prostate cancer explants by mass spectrometry. Scientific Reports, 9(1), 15008.
DOI Scopus14 WoS13 Europe PMC12 |
| 2019 |
Johnson, I. R. D., Sorvina, A., Logan, J. M., Moore, C. R., Heatlie, J. K., Parkinson-Lawrence, E. J., . . . Brooks, D. A. (2019). A paradigm in immunochemistry, revealed by monoclonal antibodies to spatially distinct epitopes on Syntenin-1. International Journal of Molecular Sciences, 20(23), 6035-1-6035-16.
DOI Scopus7 WoS7 Europe PMC5 |
| 2019 |
Hopkins, A. M., Rowland, A., Logan, J. M., & Sorich, M. J. (2019). Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansine. The breast, 46, 90-94.
DOI |
| 2013 |
Vonk, F. J., Casewell, N. R., Henkel, C. V., Heimberg, A. M., Woods, A. E., Logan, J. M., & Richardson, M. K. (2013). The king cobra genome reveals dynamic gene evolution and adaptation in the snake venom system. Proceedings of the National Academy of Sciences of the United States of America, 110(51), 20651-20656.
DOI |
